Sign in
Cost-effectiveness of abaloparatide for the treatment of postmenopausal women with osteoporosis
Conference proceeding   Peer reviewed

Cost-effectiveness of abaloparatide for the treatment of postmenopausal women with osteoporosis

M. Hiligsmann, S.A. Williams, L.A. Fitzpatrick and Jean-Yves Reginster
Osteoporosis International, 29 S1, 43-44 (2018-04); World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Cracovie, Poland [PL], du 19 au 22 avril 2018
04/2018

Abstract

General & internal medicine Human health sciences Médecine générale & interne Sciences de la santé humaine

Metrics

1 Record Views

Details